DIRS.INFO The most relevant business & tech news

☆ A bid to change the electoral math hits a roadblock: From the Politics Desk
▼ + stars: | 2024-09-23 | by ( The Politics Desk | ) www.nbcnews.com time to read: +7 min

In today's edition, our team breaks down a key Nebraska state senator's decision to stand in the way of a Trump-backed drive to change how the state allocates its electoral votes. Trump allies have pushed for a special legislative session intended for the Republican-controlled legislature to change Nebraska to a winner-take-all system instead of awarding electoral votes by congressional district. The developments appear to cap months of deliberations over whether Nebraska lawmakers could change the way the state apportions its electoral votes in a way that would benefit Trump. Nebraska allocates its electoral votes by congressional district, and the swing district around Omaha has twice gone to Democrats in recent years, giving them one electoral vote from an otherwise ruby-red state. But if lawmakers changed that to a winner-take-all model, Trump would be all but certain to win all of Nebraska’s electoral votes.

Persons: Jonathan Allen, Bridget Bowman, Adam Edelman, Katherine Doyle, Allan Smith, Ben Kamisar, Donald Trump, Sen, Mike McDonnell, Trump, Kamala Harris, Mark Murray, Democratic Party — Harris, Harris, —, Biden’s favorability, Harris ’, Trump’s favorability, Trump’s, ”, Jeff Horwitt, J D, Joh, Hou, ari, us jobs, Rea Organizations: NBC, White House, Capitol, Trump, Key, Key Nebraska Republican, Nebraska Republican, Republican, NBC News, Nebraska, Electoral, Democratic Party, Democrats, Democratic, New York Times, aig Locations: Nebraska, Key Nebraska, “, Omaha, Michigan, Pennsylvania, Wisconsin, Siena, Arizona , Georgia, North Carolina

☆ Death of Hedge Fund Stars: Wall Street, Stock Market Titans Are Gone
▼ + stars: | 2024-07-21 | by ( Linette Lopez | ) www.businessinsider.com time to read: +15 min

Take activist hedge funds, which buy up a percentage of a company's stock (or an asset) and then use their weight to push for operational changes. Or there would be a fun, splashy war between the hedge fund and the C-suite. Hedge funds rely on outperforming the market when times are hard and it's easier to find pockets of outperformance and exploit them. Of course, hedge funds are having a hard time coming up with a crew because the clients have changed too. Advertisement"At the end of the 1960s, the bubble burst, and everyone thought, 'That's the end of hedge funds,'" Mallaby said.

Persons: David Tepper, Anthony Scaramucci, Lenny Kravitz, lanyards, Bobby Jain, Goldman Sachs, Denise Shull, Charles Lemonides, ValueWorks, Saba Capital's Boaz Weinstein, BlackRock, Nelson Peltz, Bob Iger, Paul Singer's Elliott, —, Elliott, Meir Statman, Statman, I'm, That's, Paris, Marc Jacobs, they've, they're, Sebastian Mallaby, Julian Robertson, Julian, Mallaby, Lemonides, wonky quants, Keith Gill, David Einhorn, Andrew Left, bro Organizations: Appaloosa Management, Carolina Panthers, Bellagio, Millennium Management, Credit Suisse, Jain, Disney, Paul Singer's Elliott Management, Santa Clara University, Behavioral Finance, New, Tiger Management, Met, rockstar, Ferrari, Greenlight, Harvard, Princeton grad, Research Locations: Vegas , New York City, Singapore, Argentine

☆ My wife and I are both freelancers, which can be a strain on our marriage. We do these 5 things to support each other.
▼ + stars: | 2024-06-06 | by ( Shubham Davey | ) www.businessinsider.com time to read: +5 min

Read previewWe got married in February this year, and since then, my wife, Dhara, has been struggling to land freelance gigs. I have been freelance writing since 2014, and my wife started her freelance career in 2019, so I know this for a fact. My wife sent out dozens of cold emails to potential clients and got one guy to respond, but he ghosted her. To make sure we support each other and keep our marriage healthy, we follow a few important guidelines. If she understands and likes it, I know I've done well.

Persons: —, Dhara, I've, It's Organizations: Service, Business, rockstar, LinkedIn

☆ Stocks making the biggest moves midday: GameStop, Paramount, Spotify, Krispy Kreme and more
▼ + stars: | 2024-06-03 | by ( Alex Harring | ) www.cnbc.com time to read: +5 min

Waste Management , Stericycle — Waste Management is buying Stericycle for $7.2 billion , the companies announced on Monday. Stericycle shares jumped nearly 15%, while Waste Management slid 4%. Spotify — The music streaming company climbed 4% following its announcement of premium subscription price increases in the U.S. in July. Lattice Semiconductor , Coherent — Lattice shares dove 11% after CEO Jim Anderson left to take the helm at Coherent, whose stock price jumped 17%. Krispy Kreme — Shares of the company rose 2% after it was upgraded to overweight at JPMorgan.

Persons: Keith Gill, Gill, Stericycle, CNBC's David Faber, Skydance, Shari Redstone, Jim Anderson, Esam, Dickinson, Edwards, Narendra Modi, Claudia Sheinbaum, Cava, Blackwell, Krispy Kreme, Masimo, Piper, Piper Sandler, Goldman Sachs, Goldman, — CNBC's Sean Colon, Yun Li, Pia Singh, Michelle Fox, Christina Cheddar, Berk Organizations: GameStop, DeepF, AMC, New York Stock Exchange, Waste Management, Spotify, GSK, Court, Paramount Global, Lattice Semiconductor, Company, Bloomberg News, JPMorgan, Nvidia, AMD, Bank of America, Therapeutics, Autodesk Locations: U.S, Swedish, Delaware, Becton, India, Mexico

☆ Pharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuits
▼ + stars: | 2024-06-03 | by ( Jenni Reid | ) www.cnbc.com time to read: +1 min

Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. LONDON — Shares of British pharmaceuticals giant GSK plunged 9% Monday, after a U.S. court ruled that scientific evidence could be presented in a stack of lawsuits relating to the discontinued heartburn drug Zantac. The Delaware State Court late on Friday ruled that plaintiffs' expert witnesses could testify in the roughly 75,000 cases alleging the once-popular drug ranitidine — sold under the brand name Zantac in the U.S. — may cause cancer. The companies involved deny there is a scientific consensus that the drug can be linked to any later development of cancers. In a statement Friday, GSK said it disagreed with the latest Delaware ruling and would immediately seek an appeal.

Persons: ranitidine —, Brent Wisner, Wisner Baum, Zantac Organizations: GlaxoSmithKline, Stevenage, GSK, Delaware State Court, France's, Pfizer, Germany's Locations: Britain, Delaware, U.S, France's Sanofi

☆ Biotech stocks are ready to break out. They just need one more thing
▼ + stars: | 2024-04-10 | by ( Christina Cheddar Berk | In | ) www.cnbc.com time to read: +5 min

While debate rages on about when the Federal Reserve might start cutting interest rates, biotech industry analysts are making the case that the argument for stocks in the sector is growing. Last week, Morgan Stanley analysts noted that it is the months leading up to an initial rate cut when biotech stocks outperform. Morgan Stanley also believes the case for biotech stocks is further reinforced by the financing environment and the outlook for mergers and acquisitions as well as upcoming innovation. The case for innovation Morgan Stanley also favors owning biotech stocks that have a strong drug platform even if the key catalyst of clinical trial data and FDA approvals are farther out. Rhythm ranks among the stocks rated overweight that Morgan Stanley favors in this category.

Persons: Morgan Stanley, Needham, Joseph Stringer, dealmaking, Stringer, erosive, it's, Phathom, GERD, LSEG, Merck, — CNBC's Michael Bloom Organizations: Federal Reserve, Nasdaq, Oncology, Immunology, Phathom Pharmaceutical, Pharmaceuticals, Phathom Pharmaceuticals, LSEG, Drug, Bristol Myers Squibb, Pfizer, Intellia Therapeutics, Rocket Pharmaceuticals Locations: New Jersey

☆ Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts
▼ + stars: | 2024-04-05 | by ( ) edition.cnn.com time to read: +3 min

Sanofi has reached an agreement in principle to settle 4,000 US lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday. Sanofi still faces about 20,000 lawsuits over Zantac in Delaware state court. That judge concluded that the opinions of the plaintiffs’ expert witnesses that Zantac can cause cancer were not supported by sound science. “We are pushing forward aggressively against GSK and Boehringer Ingelheim and are preparing for multiple trials in California state court this year,” Moore said. Lawsuits began piling up from people who said they developed cancer after taking Zantac.

Persons: Sanofi, “ Sanofi, Boehringer, Boehringer Ingelheim, Jennifer Moore, Brent Wisner, ” Moore, Zantac, ranitidine Organizations: Court, Sanofi, GSK, Pfizer, Boehringer, US Food and Drug Administration Locations: Delaware, Zantac, Wilmington, Florida, California

☆ Kyrsten Sinema is still sitting on over $11 million in campaign cash — and she could easily use it to fuel her post-Senate life
▼ + stars: | 2024-03-11 | by ( Bryan Metzger | ) www.businessinsider.com time to read: +8 min

At the end of January, the Arizona senator reported holding nearly $10.6 million cash on hand in her campaign account and another $466,000 in her leadership PAC. AdvertisementNow, it's far from clear what will happen to those "resources" — Sinema's campaign did not respond to Business Insider's request for comment last week on the matter. There are a few different ways this could play out if Sinema decides to keep a "zombie PAC" running. Elizabeth Warren and Michael Bennet once introduced a bill to crack down on "zombie PACs." Advertisement"A lot of people use that to stay in the game because a leadership PAC is kind of a slush fund.

Persons: —, What's Sen, Kyrsten Sinema, Ruben Gallego, Kari Lake, Sinema, Arizonans, Saurav Ghosh, Ghosh, That's, Republican Sen, Rob Portman, Portman, Matt Dolan, Anna Moneymaker, he's, Kelly Ayotte, who's, Aaron Scherb, it's, She'd, she'd, Democratic Sens, Michael Bennet of Colorado, Elizabeth Warren of, Elizabeth Warren, Michael Bennet, Bill Clark, Bennet, she's, airfare, Jordan Libowitz Organizations: Service, Senate, Democrat, Democratic Rep, Business, Bloomberg, Republican, American Enterprise Institute, US, Republicans, Democratic, Daily Beast, Citizen, Washington, Commission, PAC Locations: Arizona, Ohio, New Hampshire, Elizabeth Warren of Massachusetts, Washington, Europe

WASHINGTON (AP) — The House is expected to vote to keep money flowing to scores of federal agencies before a midnight Friday shutdown deadline even as many members of the Republican conference are expected to vote against it. A significant number of House Republicans oppose the measure, forcing House Speaker Mike Johnson, R-La., to use an expedited process to bring the bill up for a vote. That process requires two-thirds of the House to vote for the measure for it to pass. Photos You Should See View All 60 ImagesJohnson countered that House Republicans have just a two-vote majority in the House while Democrats control the Senate and White House. The GOP's effort was unsuccessful for now, but supporters say they'll try again in next year's spending bills.

Persons: Mike Johnson, Johnson, “, ” Johnson, staved, they'll, ”, Rosa DeLauro, Gabrielle Giffords, Vanessa N, Gonzalez, Scott Perry, Lisa Mascaro Organizations: WASHINGTON, Republican, Congress, Republicans, Environmental Protection Agency, Alcohol, Tobacco, Firearms, Explosives, FBI, Caucus, White, WIC, House Republicans, SNAP, Strategic Petroleum Reserve, Department, Rep, Giffords, House GOP, Veterans Affairs, Agriculture, Transportation, Associated Press Locations: China

On a more positive note, Guggenheim upgraded GSK to buy thanks to strength across multiple product pipelines. Elsewhere, RBC upgraded Lyft to outperform, calling for a major rally ahead. Analyst Brad Erickson upgraded Lyft shares to outperform from sector perform, and raised his price target by $6 to $23, implying roughly 40.7% potential increase. — Pia Singh 6:10 a.m.: DoorDash upgraded by RBC on new partnerships potential, higher order growth RBC Capital Markets upgraded DoorDash to outperform from sector perform. Analyst Seamus Fernandez upgraded shares to buy from neutral and assigned a £20.31 price target, representing 21% upside to GSK's latest close.

Persons: Guggenheim, Wells Fargo, Timur Braziler, Braziler, — Pia Singh, Lyft, Brad Erickson, Erickson, Seamus Fernandez, Fernandez, Citi downgrades Ferrari, Ferrari, Harald Hendrikse, Fred Imbert Organizations: CNBC, Citi, Ferrari, GSK, RBC, Popular, RBC Capital Markets RBC Capital Markets, DASH, Capital Markets, Guggenheim Securities, drugmaker GSK, Guggenheim Locations: Wells Fargo, Puerto Rico, U.S, Wells, Shingrix, Arexvy, Milan

☆ This retailer is expected to move big this week on earnings. How to profit on it using options
▼ + stars: | 2024-03-04 | by ( Michael Khouw | ) www.cnbc.com time to read: +6 min

It refers to the estimated future volatility of the underlying asset through a future (expiration) date. Leaving the fancy options mumbo jumbo to the side, it's just another way options traders think about the price of an option . It is because inputting volatility solves for price, or inputting price solves for volatility, that options traders tend to think of the two interchangeably. Big move expected for Foot Locker In the table below, we highlight some of the stocks reporting this week where options prices estimate fairly high moves around earnings. And how does one play it given that Foot Locker options are incredibly expensive?

Persons: Foot, Locker Organizations: Big, Nike Locations: it's

☆ What, when and how you eat food affects your health, according to a doctor
▼ + stars: | 2024-02-22 | by ( Katia Hetter | ) edition.cnn.com time to read: +7 min

CNN —What you eat and don’t eat can reduce your risk of medical conditions such as heart disease and cancer and increase life expectancy, according to decades of research. Studies have linked highly processed meat with negative health outcomes, so once again look for minimally processed whole foods. I’d also urge them to cut out ultraprocessed foods, which includes junk food like chips and candies. This is not easy to do because of the sheer amount of sugar-sweetened beverages and ultra-processed food around us. If so, you may end up consuming primarily ultra-processed food, including fast food.

Persons: Leana Wen, Wen, I’d, We’ve Organizations: CNN, George Washington University

☆ Morningstar strategist names 3 under-the-radar picks for the current ‘stock picker market’
▼ + stars: | 2024-02-20 | by ( Amala Balakrishner | In Amala-Balakrishner | ) www.cnbc.com time to read: +4 min

He said it's "always a stock picker's market," but that this is even more pertinent this year. Morningstar gives the company a five-star rating, and according to Sekera it has a healthy dividend yield and is trading at a 34% discount to Morningstar's fair value. Of the 23 analysts covering the stock, 11 give it a buy or overweight rating, while 12 have hold ratings. The average price target on the stock is $39.40, according to FactSet data, giving it potential upside of 13.2%. On GSK, Sekera noted that the London Stock Exchange-listed company is trading at a 27% discount.

Persons: David Sekera, Morningstar, Sekera, Kraft Heinz, it's Organizations: U.S . Federal, CNBC Pro, Kraft Heinz, Kraft, GSK, London Stock Exchange, Reuters Locations: United States

☆ Heart disease in women: What you can do to reduce your risk
▼ + stars: | 2024-02-07 | by ( Katia Hetter | ) edition.cnn.com time to read: +8 min

Story highlights Women are more likely to have non-classic symptoms of heart attack Heart disease affects women differently than it affects men in some ways Be mindful of the risk factor that affects 44% of US womenCNN —Heart disease is the leading cause of death for women — for about 1 in 5 women — in the United States, according to the US Centers for Disease Control and Prevention. More than 60 million American women are living with some form of heart disease, yet just over half (56%) are aware that heart disease is the No. Coronary artery disease and vascular disease, or disease in blood vessels, are the leading cause of heart attacks and strokes. Another type of heart disease is heart rhythm abnormalities. Studies have shown that women have a higher likelihood of developing heart disease in the smaller arteries of their heart.

Persons: —, Leana Wen, Wen, didn’t Organizations: CNN, US Centers for Disease Control, George Washington University, CDC Locations: United States

☆ January jobs report: Expect to see strong but slower hiring and an uptick in the unemployment rate
▼ + stars: | 2024-02-02 | by ( Alicia Wallace | ) edition.cnn.com time to read: +9 min

New York CNN —The first jobs report for 2024, set to be released at 8:30 am ET Friday, is expected to underscore the strength of the US economy despite 11 rate hikes from the Federal Reserve. That can make the January jobs report among the trickiest to forecast, said Sarah House, a senior economist with Wells Fargo. Friday’s jobs report also will include the final annual benchmark review of payroll data for the 12 months that ended in March 2023. However, excluding January 2023, last month’s job cuts were the highest seen in January since 2009, according to Challenger. US worker productivity grew 3.2% in the fourth quarter, according to a BLS report released Thursday.

Persons: Jerome Powell, he’s, Sarah House, Wells, “ We’re, ”, there’s, Boussour, EY, ” Boussour, Daniel Zhao, Zhao, haven’t, ” Andrew Challenger, people’s paychecks, ” Diane Swonk, “, —, Swonk Organizations: New, New York CNN, Federal Reserve, Labor, Workers, Challenger, ”, BLS, KPMG, CNN Locations: New York, Wells Fargo, United States

☆ GSK Confidentially Settles Another Zantac Lawsuit in California
▼ + stars: | 2024-02-01 | by ( Feb. | At A.M. | ) www.usnews.com time to read: +1 min

(Reuters) -GSK said on Thursday it agreed to confidentially settle one more lawsuit in California that alleged its discontinued heartburn drug Zantac caused cancer, the latest in a series of settlements to end costly litigation. While NDMA can be present in low levels in food and water, research has found it causes cancer in larger amounts. The US Food and Drug Administration (FDA) in 2020 pulled Zantac and its generic versions off the market, triggering a wave of lawsuits. As of October, GSK still faced about 79,000 cases related to Zantac in the United States, with 73,000 of them in Delaware. Analysts have estimated total settlement costs for GSK of around $5 billion, set to be realised in the first quarter of 2024.

Persons: drugmaker, Zantac, Eva Mathews, Savio D'Souza, Rashmi Organizations: Reuters, GSK, US Food and Drug Administration Locations: California, United States, Delaware . California, Bengaluru

☆ Fed Chair Powell says the job market is still strong. Here’s how the numbers break down
▼ + stars: | 2024-02-01 | by ( Alicia Wallace | ) edition.cnn.com time to read: +9 min

That can make the January jobs report among the trickiest to forecast, said Sarah House, a senior economist with Wells Fargo. Friday’s jobs report also will include the final annual benchmark review of payroll data for the 12 months that ended in March 2023. Fresh data on job cuts and productivityOn Thursday, the layoff picture became clearer. However, excluding January 2023, last month’s job cuts were the highest seen in January since 2009, according to Challenger. US worker productivity grew 3.2% in the fourth quarter, according to a BLS report released Thursday.

Persons: Jerome Powell, he’s, Sarah House, Wells, “ We’re, ”, there’s, Boussour, EY, ” Boussour, Daniel Zhao, Zhao, haven’t, ” Andrew Challenger, people’s paychecks, ” Diane Swonk, “, —, Swonk Organizations: New, New York CNN, of Labor Statistics, Federal Reserve, Labor, Workers, Challenger, ”, BLS, KPMG, CNN Locations: New York, Wells Fargo, United States

☆ GSK CEO says RSV vaccine revenue to top 1 bln pounds in first year
▼ + stars: | 2023-11-30 | by ( Michele Gershberg | ) www.reuters.com time to read: +4 min

GSK had previously forecast 2023 sales for Arexvy between 900 million pounds and 1 billion pounds ($1.26 billion) following a strong U.S. launch. "We’re delighted with the start of our RSV vaccine," Walmsley said in a Reuters Newsmaker interview. The U.S. Food and Drug Administration (FDA) approved Arexvy for adults aged 60 years or older in May and GSK launched the vaccine in the U.S. later in the year. GSK made close to two-thirds of RSV doses given in the United States since early September, according to IQVIA data earlier this month. On Tuesday, rival Pfizer (PFE.N) said it was disappointed in the performance of its RSV shot Abrysvo compared with GSK.

Persons: Walmsley, GSK's, Emma Walmsley, We’re, David Denton, AstraZeneca's, commercialise Johnson, Ludwig Burger, Michael Erman, Josephine Mason, Kirsten Donovan, Elaine Hardcastle Organizations: GSK, Reuters, U.S . Food, Drug Administration, Pfizer, U.S, Thomson Locations: British, U.S, Europe, Japan, United States

☆ GSK lifts annual forecasts on strong launch of RSV vaccine
▼ + stars: | 2023-11-01 | by ( Eva Mathews | ) www.reuters.com time to read: +3 min

Arexvy, launched in the United States recently, recorded third quarter sales of 709 million pounds ($862 million), trouncing analysts' expectations of 358 million pounds, according to a company-compiled consensus. GSK accounts for close to two-thirds of RSV shots given in the United States since early September, according to IQVIA data. Full-year sales are seen between 900 million pounds and 1 billion pounds for the shot, GSK said. The company faces about 79,000 cases related to Zantac in the United States, with 73,000 of them in Delaware and scheduled for trial starting January 2024. For the third quarter, Shingrix, the company's top-selling drug for shingles, generated 825 million pounds in sales.

Persons: Dado Ruvic, Abrysvo, Dani Saurymper, Emma Walmsley, Eva Mathews, Maggie Fick, Tomasz Janowski, Mark Potter Organizations: GSK, GlaxoSmithKline, REUTERS, stg, CVS, Pfizer, Pacific Asset Management, GSK's, Thomson Locations: London, United States, U.S, Europe, Japan, Delaware, Bengaluru

☆ GSK raises annual forecasts powered by strong Arexvy launch
▼ + stars: | 2023-11-01 | by ( ) www.reuters.com time to read: +2 min

Analysts expect the British drugmaker's RSV vaccine Arexvy to power future growth, amid worries about the strength of its pipeline of drugs in development and costly U.S. litigation over discontinued heartburn drug Zantac. Arexvy, launched in the United States recently, is expected to garner full-year sales of between 900 million pounds to 1 billion pounds ($1.22 billion), GSK said. For the third quarter, the shot recorded sales of 709 million pounds, trouncing analysts' expectations of 358 million pounds, according to a company-compiled consensus. Meanwhile, sales are seen to rise by 12% to 13% in 2023 compared with earlier expectations of 8% to 10%. For the reported quarter, sales of Shingrix, the company's top-selling drug to treat shingles, generated 825 million pounds, below market estimates of 868 million pounds.

Persons: Dado Ruvic, Eva Mathews, Subhranshu Sahu, Tomasz Janowski Organizations: GSK, GlaxoSmithKline, REUTERS, Thomson Locations: United States, Bengaluru

The trial for the Cantlay/Harper case, which was set to begin on Nov. 13, will now be dismissed, GSK said, adding it had also settled three remaining breast cancer cases in California related to the same drug. The latest settlements in California were related to cases due to go to trial in November, with a further set scheduled to begin in Delaware courts in January, GSK said. The company still faces about 79,000 cases related to Zantac in the United States, with 73,000 of them in Delaware. GSK did not admit any liability and said it would vigorously defend itself in any other Zantac cases. In June, GSK agreed to settle a similar lawsuit in California.

Persons: Harper, Brendan McDermid, Morgan, Jeffries, Zantac, Boehringer Ingelheim, Eva Mathews, Maggie Fick, Nivedita Bhattacharjee, Bernadette Baum, Louise Heavens, Emelia Organizations: pare, Citi, GSK, Reuters, REUTERS, Barclays, Pfizer, Sanofi, FDA, Thomson Locations: California, British, Delaware, United States, Arexvy, California . California, Bengaluru, London

REUTERS/Brendan McDermid/Illustration/File Photo Acquire Licensing RightsOct 11 (Reuters) - GSK (GSK.L) on Wednesday said it would confidentially settle another lawsuit in California alleging its discontinued heartburn drug Zantac caused cancer, as the British drugmaker sought to end costly litigation. The latest settlements in California related to cases due to go to trial in November, with a further set scheduled to begin in Delaware courts in January, GSK said. The company still faces about 79,000 cases related to Zantac in the United States, with 73,000 of them in Delaware. Late in June, the company agreed to settle a similar lawsuit with California resident James Goetz who alleged he developed bladder cancer after taking Zantac. The settlement could be read that GSK sees a risk that these Zantac cases are strong enough that the company might lose at trial, J.P Morgan added.

Persons: Brendan McDermid, Morgan, Harper, Zantac, Boehringer Ingelheim, James Goetz, J.P Morgan, Eva Mathews, Maggie Fick, Nivedita Bhattacharjee, Bernadette Baum Organizations: REUTERS, GSK, Citi, J.P, Pfizer, Sanofi, FDA, Thomson Locations: California, British, Delaware, United States, Bengaluru, London

☆ GSK raises $1.1 billion from Haleon stake sale
▼ + stars: | 2023-10-06 | by ( ) www.reuters.com time to read: +2 min

REUTERS/Dado Ruvic/Illustration Acquire Licensing RightsOct 6 (Reuters) - British drugmaker GSK (GSK.L) on Friday said it raised 885.6 million pounds ($1.08 billion) from a discounted stake sale in Haleon (HLN.L), cutting its shareholding to 7.4% in the world's largest standalone consumer healthcare firm. The sale of 270 million shares at 328 pence apiece, represented a discount of about 2.5% to Haleon's last close of 336.25 pence on Thursday. Shares in Haleon were down 1.2% while GSK was marginally up 0.4% at 0800 GMT. Pfizer, which holds a 32% stake in Haleon, said in May it plans to cut its ownership in a "slow and methodical" manner within months. The British drugmaker and Pfizer have agreed to not sell any further Haleon shares for 60 days from the settlement of placing.

Persons: Dado Ruvic, Emma Walmsley, Prerna Bedi, Sonia Cheema, Elaine Hardcastle Organizations: GSK, GlaxoSmithKline, REUTERS, British, AstraZeneca, London Stock Exchange, Pfizer, Thomson Locations: Haleon, British, Bengaluru

LOS ANGELES (AP) — Bruce Springsteen and the E Street Band's 2023 tour will be postponed until 2024, citing doctor's advice. The Boss, who last week celebrated his 74th birthday, is “steadily recovering” from peptic ulcer disease, a press release read. The newly postponed shows include Canadian dates and a West Coast run of Phoenix, San Diego, Los Angeles, and San Francisco. Peptic ulcer disease can be dangerous, leading to bleeding and emergency situations such as perforation of the ulcer through the stomach. People who are treated “recover completely from peptic ulcer disease,” Dr. Lawrence Kosinski of the American Gastroenterological Association told AP.

Persons: — Bruce Springsteen, ”, Springsteen, Dr, Lawrence Kosinski, “ Organizations: ANGELES, American Gastroenterological Association, AP, ” Locations: Baltimore , Philadelphia, Albany, Syracuse, New York, Pittsburgh, Washington, Connecticut, Ohio, West, Phoenix, San Diego , Los Angeles, San Francisco, Tampa , Florida

But the challenge facing Fulton County Judge Scott McAfee in Georgia is unlike any of the others. For one, he is the only judge so far to allow television cameras in the courtroom to broadcast hearings and any trials. And the trials will play out in a battleground state that Trump narrowly lost in 2020. But the experience of some judges who have been thrust into the public eye point to potential pitfalls and dangers ahead for the 34-year-old Georgia native. “Hopefully, you have a life outside the law,” Cahill said during his talk in Reno about handling high-profile cases.

Persons: Peter Cahill, Derek Chauvin, George Floyd, you’re, ”, Donald Trump, Scott McAfee, Rudy Giuliani, Mark Meadows, McAfee, Aileen Cannon, Reggie Walton, Lewis ” Scooter, Libby, Dick Cheney, Roger Clemens, “, Lance Ito, Simpson, Critics, Jay Leno ”, Elizabeth Scherer, Nikolas Cruz, Cruz, Scherer, Eric Davis, Tanya Chutkan, Ito, Judy, he's, Han Chung, Chung, Trump's, E, Susan Garsh, Aaron Hernandez, ” Garsh, Fani Willis, Trump, Willis, — Chutkan, Barack Obama, Juan Manuel Merchan, Merchan, Chutkan, Brian Kemp, Kemp, ” Cahill Organizations: ATLANTA, Minnesota, National Judicial College, New York, Trump White House, Trump, Georgia, Senior, Associated Press, Los Angeles Superior, Delaware, Systems, Fox News, American Bar Association, U.S, New Yorker, McAfee, Massachusetts, New England Patriots, AP, Patriots, University of Georgia, Republican, Federalist Society, Emory University, Georgia Aquarium Locations: Minneapolis, Reno , Nevada, Fulton, Georgia, U.S, Florida, Los, Parkland, Washington, Fulton County, Gwinnett County, Reno

Search resuls for: "heartburn"

25 mentions found